Human-induced pluripotent stem cell-derived cardiomyocyte sheets can be a life-saving intervention for patients with advanced cardiovascular disease. Administration of immunosuppressive agents to ...

Announcing a new article publication for BIO Integration journal. Cardiac cell death and myocardial fibrosis after ischemia-reperfusion (I/R) injury are the primary causes of impaired cardiac function ...

Cardiovascular disease remains the leading cause of mortality worldwide, necessitating deeper insights into its molecular underpinnings beyond genetic predisposition. Epigenetic modifications, ...

Reintroduction of the Cyclin A2 gene enables adult human cardiomyocytes to divide, producing functional daughter cells and promoting heart repair. The therapy uses a replication-deficient adenoviral ...

The induction of the cell cycle in cardiomyocytes involves the activation of specific genes that are responsible for regulating cell division and growth. Our laboratory has discovered several ...

In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...

Prevalence and temporal trends of prostate cancer among patients with acute cardiovascular diseases in the United States: A National Inpatient Sample analysis.

Maestro MEA Platform Powers First Stem Cell Cardiac Safety Assay in FDA ISTAND ProgramThe Associated PressATLANTA ATLANTA–(BUSINESS WIRE)–Feb 18, 2026– Axion BioSystems today announced that the FDA’s ...

A Japanese panel of experts on Thursday gave the green light for the health minister to approve the production and sale of two regenerative medical products that use induced pluripotent stem, or iPS, ...